Network origin in Amrik Basran first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
59
| Public Company | Pharmaceuticals: Major | 59 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Amrik Basran via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Independent Dir/Board Member Director of Finance/CFO Director of Finance/CFO | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Oxford | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Glasgow | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Founder Corporate Officer/Principal | |
| St. Joseph's University | College/University | Undergraduate Degree Masters Business Admin | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | President Chief Executive Officer | |
| North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree | |
| ABLYNX | Biotechnology | Chairman Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Private Equity Investor | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
 GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
BioEclipse Therapeutics, Inc.
 BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
Eversana Life Science Services LLC
 Eversana Life Science Services LLC Miscellaneous Commercial ServicesCommercial Services EVERSANA Life Science Services LLC engages in the provision of global services to the life science industry. It offers pricing, reimbursement and market access, global channel management, revenue management, and affordability programs. The company is headquartered in Milwaukee, WI. | Miscellaneous Commercial Services | Director/Board Member | |
CHD Bioscience, Inc.
 CHD Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services CHD Bioscience, Inc. develops and manufactures disinfectants for healthcare and food industries. The company is headquartered in Fort Collins, CO. | Miscellaneous Commercial Services | Director/Board Member | |
| World Affairs Council of Philadelphia | Director/Board Member | ||
Sohn Health Strategies LLC
 Sohn Health Strategies LLC Miscellaneous Commercial ServicesCommercial Services Sohn Health Strategies LLC provides business development and new product marketing consulting services. The American company was founded by Catherine Angell Sohn. | Miscellaneous Commercial Services | Founder | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| University of the Sciences in Philadelphia | College/University | Corporate Officer/Principal | |
| Consumer Healthcare Products Association | Director/Board Member | ||
Dohmen Co.
 Dohmen Co. Data Processing ServicesTechnology Services Dohmen Co. operates as a retail pharmacy agency that provides outsourced healthcare services. Its services include supply chain, customer and patient support, technology, financial, consulting, and quality and regulatory services. The company was founded by Friedrich W. Dohmen in 1858 and is headquartered in Milwaukee, WI. | Data Processing Services | Director/Board Member | |
Ariel Pharmaceuticals, Inc.
 Ariel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ariel Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Broomfield, CO. The company was founded by Steve A. Orndorff. | Pharmaceuticals: Major | Director/Board Member | |
| LIFECORE BIOMEDICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| European Molecular Biology Organization | Corporate Officer/Principal | ||
| Solvay Business School of Economics & Management | College/University | Undergraduate Degree | |
| Ossianix Uk Ltd. | Director/Board Member | ||
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 29 |
| United Kingdom | 15 |
| Ireland | 3 |
| Belgium | 3 |
| France | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 2 |
Operational
| Director/Board Member | 256 |
| Corporate Officer/Principal | 162 |
| Independent Dir/Board Member | 79 |
| Chairman | 60 |
| Chief Executive Officer | 49 |
Most connected contacts
| Insiders | |
|---|---|
| Anne Michelle Whitaker | 35 |
| James Murdoch | 32 |
| Simon Dingemans | 31 |
| Russell Greig | 31 |
| Catherine Sohn | 27 |
| Michael Owen | 20 |
| Ian Maurice Gray Prosser | 19 |
| Judy Lewent | 19 |
| Stacey Cartwright | 17 |
| Marc Dunoyer | 16 |
| John Donofrio | 16 |
| Paul-Peter Tak | 15 |
| Yvonne Greenstreet | 15 |
| Ellen Strahlman | 14 |
| Kimberly Murphy | 13 |
- Stock Market
- Insiders
- Amrik Basran
- Company connections
